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 Conclusion:  Assessment of mRNA expression in urinary sed-
iment is a non-invasive method applicable to gain insights 
into the pathophysiology of inherited nephropathies in hu-
mans.  HNF1B nephropathy is generally not associated with 
postnatal down-expression of renal cystic genes in human, 
a finding consistent with mouse models.
 Copyright © 2012 S. Karger AG, Basel
 Introduction
 In humans,  HNF1B  (hepatocyte nuclear factor-1  ) 
mutations result in a multisystem disease with autoso-
mal dominant inheritance. In accordance with the role 
of  HNF1B during development, the pancreas, genital 
tract, liver and kidneys may all be affected, resulting in 
maturity-onset diabetes of the young type 5, genital mal-
formations, liver tests abnormalities and nephropathy 
 [1–3] . In mouse kidney,  Hnf1b is expressed in all the 
nephron segments, from proximal tubule to collecting 
duct  [4] . Renal phenotype in  HNF1B -related disease is 
highly heterogeneous. It mostly encompasses (1) bilat-
eral renal hypodysplasia most often translating into hy-
perechogenic kidneys or renal cortical cysts from the an-
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 Abstract
 Background/Aims: HNF1B nephropathy is characterized by 
dominantly inherited renal hypodysplasia with few cysts, 
slow renal decline and hypomagnesemia. Mice with antena-
tal inactivation of  HNF1B  are characterized by polycystic kid-
neys, renal failure and a profound decrease in cystic gene 
 (Pkhd1 ,  Umod ,  Pkd2) expression. Mice with inactivation after 
postnatal day 10 have no renal phenotype.  Methods: Quan-
tification of mRNA expression of  HNF1B,  six of its potential 
target genes  (PKHD1 ,  PKD1 ,  PKD2 ,  IFT88 ,  TMEM27 and  UMOD) 
and three genes involved in the Mg 2+  renal homeostasis 
 (ATP1A1 ,  FXYD2 and  CLDN16) in the urinary sediment of 11 in-
dividuals with mutation of  HNF1B and in 9 controls (non-in-
vasive assessment of the renal transcriptome).  Results: As 
compared to controls, no difference was observed in the uri-
nary mRNA amount of  HNF1B  and the renal cystic genes. A 
significant increase in the expression of  ATP1A1 , which en-
codes the   1-subunit of the Na + /K + -ATPase, was identified in 
 HNF1B  patients consistent with its role in Mg 2+  homeostasis. 
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tenatal period through childhood; (2) in adulthood, re-
nal cysts are frequently lacking or few, and (3) at any age, 
the nephropathy harbors a profile of chronic tubuloint-
erstitial nephritis with slowly progressive renal decline, 
low-range proteinuria without hematuria, and a distinc-
tive renal loss of magnesium and potassium  [1, 5, 6] . In 
addition, we and others have emphasized a wide inter- 
and intra-family variability  [5, 7] . Beside whole-gene de-
letions, which account for more than half of all muta-
tions  [8] , private heterozygous point mutations of  HNF1B 
have been reported, including missense, nonsense, 
frameshift and splicing mutations  [7] . Molecular mecha-
nisms underlying the clinical heterogeneity are current-
ly unknown and may involve stochastic effects or modi-
fying genes.
 While  Hnf1b +/–  mice are fertile and do not exhibit re-
nal involvement,  Hnf1b –/–  die early in embryogenesis due 
to the lack of visceral endoderm differentiation  [9] . In 
mice, biallelic renal-specific  Hnf1b invalidation leads to 
polycystic kidney disease and early renal failure  [10] . 
Gresh et al.  [10] showed that  Hnf1b controls a large tran-
scriptional network including genes coding for proteins 
that co-localize to the primary cilium, a structure in-
volved in epithelial cells proliferation and planar cell po-
larity  [11] . Hence, a significant down-regulation of the 
renal expression of  Tmem27 ,  Ift88 ,  Umod ,  Pkd2 and  Pkhd1 
 was observed in this model  [10, 12] . Given their implica-
tion in renal cystic diseases, these genes were collectively 
referred to as ‘renal cystic genes’. More recently, Verde-
guer et al.  [13] showed that renal-specific invalidation of 
 Hnf1b after postnatal day 10 was not followed by a down-
regulation of these renal cystic genes, except for the  Umod 
gene, while transient increase in epithelial cell prolifera-
tion (induced by ischemic acute kidney injury) promoted 
cystic kidney disease in this model.
 In an attempt to confirm these findings in humans 
and to decipher the molecular mechanisms of magne-
sium renal loss, we used a direct approach relying on 
mRNA expression analysis in urinary sediment. This 
method has been established as a non-invasive tool to di-
agnose renal allograft rejection  [14, 15] and more recent-
ly, to determine gene expression in podocytes and tubular 
epithelial cells in the mouse  [16, 17] and in humans  [3, 18] . 
We assessed the expression of  HNF1B and of six cystic 
genes  PKHD1 ,  PKD1 ,  PKD2 ,  IFT88 ,  TMEM27 and  UMOD 
in urinary cells of 11  HNF1B -mutation carriers ( HNF1B 
patients) and 9 controls. We extended the analysis to uri-
nary expression of  ATP1A1 ,  FXYD2 and  CLDN16 , which 
respectively encode for the   1 and the   -subunit of the 
Na + /K + -ATPase and claudin-16. These genes are involved 
in magnesium homeostasis and the latter two have been 
found mutated in familial hypomagnesemia  [19, 20] . 
Limited availability of mRNA did not allow to assess the 
mRNA of  TRPM6 ,  EGFR and  KV1.1 , three additional 
genes involved in the fine tuning of Mg 2+  in the distal 
convoluted tubule  [21–23] .
 Patients and Methods
 Patients and Controls
 Patients were recruited in the Renal Pediatric Unit at Univer-
sity Hospital of Toulouse, France. Genotyping of  HNF1B  was per-
formed in all patients as previously recommended  [8] : quantita-
tive multiplex PCR of short fragment (QMPSF) was applied to 
identify gene deletion, followed by direct sequencing of the nine 
exons and all exon-intron boundaries in patients with normal 
QMPSF.
 Clinical history of renal and extrarenal involvement in the 
 HNF1B patients was recorded through a standardized assessment 
of the patient’s hospital records. According to age, estimated glo-
merular filtration rate (eGFR) was calculated using the simplified 
MDRD formula or Schwarz formula in individuals  ! 16 years old. 
Hypomagnesemia was defined by serum magnesium level  ! 0.75 
mmol/l. Imaging studies of the kidney consisting of ultrasonog-
raphy and/or computed tomography were recorded. Diabetes was 
diagnosed on the basis of receiving either insulin or oral agents, 
or biochemical evidence of diabetes in accordance with WHO 
guidelines. Pancreas imaging (ultrasonography before 15 years of 
age and computed tomography scan thereafter) was performed in 
all patients.
 Controls consisted of 9 healthy young individuals [5 males and 
4 females, median age 38 years (25–47)]. Seven were first-degree 
relatives of the  HNF1B cohort, for whom genetic testing ruled out 
a mutation of  HNF1B . According to the French law, informed 
written consent was obtained from all subjects and tested rela-
tives, and the study was conducted in agreement with the prin-
ciples of the Declaration of Helsinki.
 Immunostaining of Urinary Cells
 Freshly voided urine (100 ml) of a control individual was cen-
trifuged at 700  g for 10 min. Supernatant was carefully aspirated 
and the sediment pellets was washed twice with phosphate-buff-
ered saline (PBS). The pellet was then resuspended in 500   l of 
PBS. The resuspended sediment was then spun onto slides, which 
were air-dried and then fixed with 3% paraformaldehyde at room 
temperature for 15 min. After washing with PBS, the slides were 
incubated with anti-human cadherin-16 antibody (Abcam 
ab64868) at a dilution of 1:  100 for 60 min. After being washed 
with PBS, a biotin-conjugated secondary antibody and subse-
quent streptavidin-biotin complex formation was performed ac-
cording to manufacturer’s instructions. The sediment was coun-
terstained with DAPI nuclear stain to distinguish whole cells 
from cells fragments.
 Urinary Cell RNA Isolation
 To avoid technical bias related to urinary sampling, 2–5 (me-
dian 3) diurnal micturitions [median volume 80 ml (25–150)] 
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were collected from each patient. Isolation and lysis of urinary 
cells and RNA extractions were performed using the  ZR Urine 
RNA isolation kit TM   (Zymo Research, Orange, Calif., USA) ac-
cording to the manufacturer’s protocol. RNA quality was assessed 
by measurement of the optical density 260/280 ratio with a target 
optical density ratio  1 1.7, as previously recommended  [14] .
 Real-Time Quantitative PCR
 cDNA were generated from urinary cell RNAs and quantified 
using the Verso TM  SYBR Green 2-Step qRT-PCR Fluorescein re-
agent (ThermoScientific-Fisher, Illkirch, France). The primers 
were designed using Primer3 software [http://biotools.umassmed.
edu/bioapps/primer3_www.cgi]. Their sequence is provided in 
online supplementary table 1 (for all suppl. material, see www.
karger.com/doi/10.1159/000334954). The efficiency of each set of 
primers was assessed by dilution curves and the Ct differences 
between the reference  (GAPDH) and target genes calculated for 
each sample of each patient. The formula used to quantify the 
relative changes in target over  GAPDH mRNAs between the two 
groups is derived from the 2 –  Ct  formula recommended by
Pfaffl  [24] . The RT-PCR conditions were as follows: 51   °   C for 60 
min, 95   °   C for 2 min. q-PCR was carried out on an ABI PRISM  
7600 sequence detection system using SYBR  green with the fol-
lowing conditions: 95   °   C for 15 min followed by 40 cycles (95   °   C 
for 30 s, 58   °   C for 30 s, and 72   °   C for 1 min).
 Statistical Analysis
 Data are presented as absolute medians and limits. Significant 
differences between  HNF1B patients and control were tested by 
the Mann-Whitney test. p values  ! 0.05 were considered signifi-
cant.
 Results
 Clinical, Genetic and Biological Characteristics of 
HNF1B Patients
 We studied 11  HNF1B patients (7 children and 4 indi-
viduals  6 16 years old; 7 males and 4 females) at a median 
age of 4 years (range 2–40), belonging to nine unrelated 
families ( fig. 1 ). Familial screening indicated that the mu-
tation occurred de novo in seven families. Molecular 
analysis of  HNF1B identified a whole-gene deletion in
7 patients and point mutations in 4 (c.185-1A 1 G, 
p.Gln253Pro, p.Asn289Asp and p.Gly456X), a distribu-
tion observed in previous studies  [3, 8] .
 Phenotypes of the  HNF1B patients are summarized in 
 table 1 . Renal disorder was the first symptom identified 
in all patients except in patient 6.1 who presented with 
infertility and genital tract malformation. Briefly, 4 out 
of the 11 patients had chronic renal failure (CKD stage 
1–3) according to their estimated creatinine clearance 
(23, 38, 45 and 64 ml/min at 16, 18, 21 and 40 years of age, 
respectively). Low serum magnesium (0.61–0.70 mmol/l) 
was found in 4 patients. All of them had increased uri-
nary magnesium excretion (as defined by the ratio of 
magnesium to creatinine clearances) from 5 to 9%.
 Renal imaging detected a solitary kidney in 6 individu-
als, including 2 with hypoplastic kidney (patients F1.1 and 
F2.1); in 4, yearly abdominal imaging demonstrated slow 
involution of their multicystic dysplastic kidney. Among 
# #
1 1 1
F1
p.Gln253Pro
1 1
1
2 3
F2
deletion
F6
deletion
Organ
involvement
F7
deletion
F8
p.Gly486X
F4
deletion
F5
deletion
F3
c.185.1G>A
1 1
F9
p.Arg289Asp
1
Kidney # Genotype
not available
Genital tractPancreas Liver
 Fig. 1. Summary of phenotype and geno-
type changes in nine French families with 
 HNF1B mutation. Individuals recruited 
for urinary transcriptome analysis in the 
study are identified by a number. 
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the remaining patients, imaging showed unilateral hypo-
plastic kidney (n = 1), bilateral hypoplastic kidneys (n = 1) 
or bilateral normal sized kidneys (n = 3). Renal cysts were 
observed in 8 individuals (multicystic dysplastic kidney in 
1 and few cysts in 7). Renal hyperechogenicity was identi-
fied in 8 individuals (mainly of pediatric age). Patient 6.1 
had a solitary ectopic kidney with few cysts diagnosed at 
age 36, while his 2 children had hyperechogenic kidneys 
with few cysts diagnosed antenatally.
 mRNA Expression in Urinary Sediment
 Using immunostaining of urinary cells with an anti-
body directed against the kidney-specific cadherin, cad-
herin-16, we first confirmed in a control individual that 
renal tubular cells may be collected and analyzed from 
urine sample (see supplementary data). The renal/uro-
thelial cell ratio was almost 1/10. After urinary cell isola-
tion and lysis, mRNA was extracted and reverse tran-
scribed. Thereafter, we confirmed that renal cells collect-
ed in urine come from the different tubular segments, as 
demonstrated by RT-PCR using specific primers of  AQP1 , 
 UMOD ,  CLDN16 ,  AQP2 and  AVPR2 (data not shown). 
Leukocyturia was ruled out in all patients with urinary 
dipstick.
10–6
10–5
10–4
10–3
10–2
10–1
Mut. Cont.
HNF1B
Re
la
ti
ve
 m
RN
A
 q
ua
n
ti
fic
at
io
n
 in
 u
ri
n
ar
y 
ce
lls
NS
 Fig. 2. mRNA levels of HNF1B in urinary cells of 11 patients with 
HNF1B mutation and 9 control individuals. Dots represent the 
quantification levels of  HNF1B  normalized mRNA (2 –  Ct ) rela-
tive to the quantity of  GAPDH transcripts.  I  = Whole-gene dele-
tion;  y  = point mutation.
 Table 1. C linical and genetic characteristics of 11 individuals from nine unrelated families with  HNF1B mutation
Patient Age
years
Gender Mutation Kidney malformations CRF Serum Mg 2+  level
(N: 0.75–1 m M )
Pancreas
abnormalities
Liver test
abnormalities
Genital tract
abnormalities
F1.1 3 M p.Glu253Pro Hypoplastic horseshoe kidney, 
few cysts, HE
No Normal No Yes NA
F2.1 4 F Deletion Right: involution
Left: hypoplastic, one cyst, HE
No Normal No Yes NA
F3.1 16 M c.185–1G>A Right: normal 
Left: involution
Yes 0.7 mmol/l Hypoplastic
Low fecal elastase
No NA
F4.1 4 M Deletion Right: MCDK, HE
Left: hypoplastic 
No 0.61 mmol/l No Yes NA
F5.1 18 M Deletion Right: hypoplastic, HE
Left: hypoplastic, HE
Yes Normal No No NA
F6.1 40 M Deletion Right: few cysts, pyelic dilatation
Left: absent
Yes 0.65 mmol/l Hypoplastic No BAVD
Ectopic testis
F6.2 4 F Deletion Right: few cysts, HE
Left: few cysts, HE
No Normal No Yes Ectopic testis
F6.3 4 M Deletion Right: few cysts, HE
Left: few cysts, HE
No 0.7 mmol/l No Yes NA
F7 4 M Deletion Right: few cysts, HE
Left: few cysts, HE
No Normal No Yes NA
F8 2 F p.Gly456X Right: involution
Left: few cysts, HE
No Normal No No NA
F9 21 F p.Arg289Asp Right: absent
Left: normal
Yes Normal No No No
C RF = Chronic renal failure (eGFR <60 ml/min/1.73 m 2 , according to simplified MDRD formula, or Schwarz formula in individuals <16 years); 
HE = hyperechogenicity; MCDK = multicystic dysplastic kidney; BAVD = bilateral absence of vas deferens; NA = not available.
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 Relative quantification of the expression of  HNF1B 
mRNA in urinary cells showed no difference in tran-
script levels between  HNF1B patients and controls 
( fig. 2 ). In the subgroup of 7 patients with  HNF1B  whole-
gene deletions in whom a decrease of expression levels 
of 50% could be anticipated from haploinsufficiency,
no significant difference in  HNF1B  expression was de-
tected.
 We next examined the expression of potential target 
genes of  HNF1B in humans and observed that the ex-
pression of  UMOD ,  PKHD1 ,  PKD1 ,  PKD2 ,  TMEM27 and 
 IFT88 mRNAs were not statistically different between 
patients and controls ( fig. 3 ). Neither the age at enrol-
ment into the study nor the type of  HNF1B mutation 
affected relative expressions of these genes (data not 
shown).
 Finally, we assessed the expression of three additional 
transcripts involved in magnesium homeostasis,  ATP1A1 
(encoding for the   1-subunit of the Na + /K + -ATPase), 
 FXYD2 (encoding for the   -subunit of the Na + /K + -
ATPase) and  CLDN16 (which encodes for claudin-16). 
The normalized expression of  ATP1A1 mRNA was sig-
nificantly higher in  HNF1B patients compared to con-
trols (sixfold, p = 0.009) while no difference was detected 
in expression of  FXYD2 and  CLDN16 ( fig. 4 ).  ATP1A1, 
FXYD2  and CLDN16 mRNA expression was not corre-
lated with serum magnesium level (data not shown).
 Discussion
 To investigate whether  HNF1B -related nephropathy is 
associated with a peculiar postnatal profile of renal cystic 
genes in human, we performed a non-invasive expression 
10–6
10–5
10–4
10–2
1
10–3
10–1
101
Mut. Cont.
UMOD
NS NS NS NS NS
Mut. Cont.
PKD1
Mut. Cont.
PKD2
Mut. Cont.
PKHD1
Mut. Cont.
Collectrin
Mut. Cont.
IFT88
NS
 Fig. 3. mRNA levels of UMOD, PKD1, 
PKD2, PKHD1, TMEM27 and IFT88 in 
urinary cells of 11 patients carrying a mu-
tation of HNF1B and 9 control individuals. 
The box-plot representation shows the me-
dians and the percentile values 10, 25, 75, 
and 90 for the quantification levels of nor-
malized mRNA (2 –  Ct ) relative to the 
quantity of  GAPDH transcripts.
10–6
10–5
10–4
1
10–1
10–2
10–3
101
Mut. Cont.
FXYD2
NS
Mut. Cont.
CLDN16
NS
Mut. Cont.
ATP1A1
6× (p = 0.009)
 Fig. 4. mRNA levels of FXYD2, CLDN16 and ATP1A1 in urinary 
cells of 11 patients carrying a mutation of HNF1B and 9 control 
individuals. The box-plot representation shows the medians and 
the percentile values 10, 25, 75, and 90 for the quantification levels 
of normalized mRNA (2 –  Ct ) relative to the quantity of  GAPDH 
transcripts. 
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analysis following collection of urinary cells in 11 pa-
tients aged between 2 and 40 years. We also used this 
method to investigate whether hypomagnesemia ob-
served in patients with  HNF1B -related nephropathy is as-
sociated with differences in expression of genes involved 
in Mg 2+  metabolism. The main limit of this study is the 
high degree of variability of the tubular to urothelial cells 
ratio that may be collected in urine samples. Subsequent-
ly, high variability of expression levels was observed when 
GAPDH was used as reference gene. Because renal tran-
scriptomic changes are currently unknown in patients 
with  HNF1B mutations and  Hnf1b may modify expres-
sion of segment-specific tubular markers in the mouse, 
we could not use them as reference gene. Note, previous 
studies have shown that GAPDH may be used as refer-
ence gene to identify intra-renal mRNA changes  [17] . 
Lastly, we did not use  HNF1B itself as reference gene be-
cause of its expression in urothelial cells  [4] and the lack 
of data concerning its expression in each tubular segment 
in adult normal and  HNF1B patients.
 In these 11 patients with heterogeneous renal pheno-
type, including 7 with a whole-gene deletion, we did not 
observe any change in expression of  HNF1B mRNA as 
compared to controls, suggesting that after antenatal pe-
riod, one copy of  HNF1B could be sufficient to reach nor-
mal expression of this gene in postnatal kidney. 
 The lack of down-regulation of renal cystic genes may 
account for the low cystic involvement in most patients of 
this series diagnosed with  HNF1B -related nephropathy 
in adulthood, as exemplified in patients F3.1, F5.1, F6.1 
and F9, in whom imaging studies exhibited no or few 
renal cysts. This is reminiscent of pathological findings 
from our early experience: rare cysts of glomerular or tu-
bular origin were observed on kidney specimens from 6 
unrelated individuals  [1] .
 The lack of postnatal detectable difference in expres-
sion level of  HNF1B and related cystic genes in  HNF1B -
mutated individuals is not entirely unexpected according 
to previous findings. First, genetic discrepancies between 
mouse models and human disease suggest that the under-
lying molecular mechanisms are different. In contrast to 
rodent models, which share recessive inheritance at tissue 
level  [9, 10, 12] ,  HNF1B -related human disease is domi-
nantly inherited  [25] . While a significant down-regula-
tion of the expression of renal cystic genes  Tmem27 ,  Ift88 , 
 Umod ,  Pkd2 and  Pkhd1 was observed postnatally in mice 
with antenatal renal-specific conditional inactivation of 
 Hnf1B  [10, 12] , a sustained expression of  PKD1 ,  PKD2 and 
PKHD1  was observed in epithelial cells layering both cys-
tic and non-cystic renal structures of two  HNF1B -mutat-
ed human fetuses  [26] . This could be related to the per-
sistent expression of the non-mutated allele. Moreover, 
there is no evidence for a two-hit process within renal tis-
sue in  HNF1B individuals, with the exception of somatic 
deletion of the second allele in neoplastic tissue of the rare 
individuals who developed chromophobe renal carcino-
ma superimposed on  HNF1B nephropathy  [27] . Second, 
target genes of transcription factors may widely diverge 
between humans and mice. This applies to the HNF fam-
ily, with recent recognition of a 40–80% divergence 
among HNF1A and HNF4A target genes between mouse 
and human  [28] . Of note, the overexpression of  HNF1B 
in a human embryonic kidney cell line (HEK293) was not 
followed by an up-regulation of the target genes of  Hnf1b 
previously identified in a mouse model  [29] . Finally, ro-
dent models have recently shed light on the key role of 
 Hnf1b in the transcriptional switch occurring at the end 
of the kidney maturation process, around postnatal day 
10 (P10)  [13] . While conditional renal-specific inactiva-
tion of  Hnf1b in embryos and neonates until P3 results in 
severe polycystic kidney disease, no cystic lesions develop 
in mice induced at P10 or later and renal transcriptome 
analysis demonstrated a sustained expression of cystic 
genes  (Pkd2 ,  Pkhd1 ,  Kif12 ,  Tmem27) . This finding is con-
sistent with the lack of difference of urinary mRNA 
amounts of  PKHD1 ,  PKD2 and  TMEM27 between pa-
tients and controls investigated in this study. Our study 
highly suggests that the expression of most cystic genes 
in human quiescent renal cells is not dependent of  HNF1B . 
Thus the exact role of  HNF1B  in adult human kidney re-
mains to be defined.
 In adults, mutations of  HNF1B may be associated with 
low serum magnesium or low serum potassium level due 
to renal loss of either ion  [5, 30] . These peculiar findings 
have not been reported so far in animal models, which 
hampers molecular analysis. Among the 11 patients test-
ed in this series, urinary loss of magnesium and potassi-
um were identified in 4 and 2 individuals, respectively. 
Renal magnesium homeostasis is a complex physiological 
process that involves many transporters and receptors 
(e.g. claudin-16, claudin-19, Na + /K + -ATPase) all along the 
different tubular segments (see review by Naderi and 
Reilly  [31] ). We tested here the expression of  CLDN16 
 (claudin-16),  FXYD2 and  ATP1A1  (encoding for the   -
subunit and the   1 -subunit of the Na + /K + -ATPase) in re-
nal tubular cells of  HNF1B patients. We found a sixfold 
increase in mRNA of  ATP1A1 of  HNF1B patients while 
mRNA expression of  CLDN16 and  FXYD2 were not dif-
ferent in patients and controls ( fig. 4 ). At first glance, the 
up-regulation of the Na + /K + -ATPase seems to be consis-
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tent with its role for maintenance of the transepithelial 
electrical gradient required for renal magnesium paracel-
lular reabsorption. However, whether  ATP1A1 is a direct 
target of HNF1B in the human kidney remains unknown. 
Using the Consite program [http://asp.ii.uib.no:8090/cgi-
bin/CONSITE/consite], we failed to identify any putative 
 HNF1B binding site in the 4,000 bp preceding the first 
 ATP1A1 exon. Changes in the level of  ATP1A1 expression 
may be a functional consequence of hypomagnesemia 
rather than a direct effect of  HNF1B , since mutations of 
 ATP1A1 have not yet been described in humans. Recent-
ly, in our study performed before a report showing that 
 HNF1B increased expression of a specific isoform of 
 FXYD2  in vitro  [30] , we failed to show a decrease in uri-
nary amounts of  FXYD2  mRNA in  HNF1B -mutated pa-
tients but we only assessed the overall expression of 
 FXYD2 in urinary cells regardless of various isoform-
specific expressions. Limited availability of mRNA did 
not allow us to assess the relative expression of the vari-
ous isoforms of  FXYD2 .
 In summary, we show here that measurement of 
mRNA expression in urinary sediment is a valuable ap-
proach to assess the renal epithelial transcriptome in in-
herited renal diseases. We demonstrate that the expres-
sion of cystic renal disease genes, previously recognized 
as target genes of  Hnf1b in mouse, are not dramatically 
reduced in postnatal (quiescent) renal epithelial cells of 
human patients carrying a mutation of  HNF1B , thus con-
firming distinct functions of the  HNF1B transcription 
factor during nephrogenesis and in the mature kidney. 
Further studies will have to confirm and expand these 
preliminary results obtained in a small cohort of patients 
in order to decipher the transcriptional network involv-
ing  HNF1B in postnatal human kidney.
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